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Introduction
 Breast cancer is a serious and potentially lethal disease 
among 40-50 aged women and its incident rate is one out 
of eight in the United States and one out of thirty five 
people in Asia. Incidence of breast carcinoma is 10 per 
100,000 of population with 7000 new cases annually in 
Iran. The age specific rate in females is 23.16/100,000. 
Every year 1200 women die due to breast carcinoma 
with burden of 0/31 DALY/1000, which is the third in 
ranking of burden of disease (BOD) among women and 
seventh rank in both sexes. It is expected that the number 
of new cases will rise up to 20,000,000 by 2015 globally 
and 12,000,000 deaths annually 70% of which will occur 
in developing countries (Akbari et al., 2011; Haghighat 
et al., 2012). It is a multi-factor disease, genetically 
mutation and environmental condition plays important 
role in the breast cancer (Madigan et al., 1995). Only 
5-10 percent of the breast cancer patients have a known 
mutation and about 70% of breast cancer patient are 
not related to genetically mutation. The breast cancer is 
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Abstract
 Breast cancer is a serious and potentially lethal multi-factor disease among 40-50 aged women in both 
developed and developing countries. Also, various studies have pointed to roles of neurotransmitters like serotonin 
in development of cancers, through action on various types of receptors. This study was conducted to evaluate 
serotonin receptor (5HT2AR and 5HT3AR) genes expression in peripheral blood mononuclear cells (PBMCs) 
of breast cancer patients in comparison with the healthy people and in the MCF7 cell line. Peripheral blood 
samples were obtained from 30 patients and 30 healthy individuals. Total RNA was extracted from PBMCs and 
MCF-7 cells. and 5HT2AR and 5HT3AR were detected by RT-PCR techniques. Finally, serotonin receptor gene 
expression variation in breast cancer patients and MCF-7 cells were determined by real time-PCR. This latter 
indicated significant promotion in expression of 5HT3AR and 5HT2AR in PBMCs in breast cancer patients 
but expression of 5HT2AR in the MCF-7 cell line was significantly decreased. In conclusion, after performing 
complimentary tests, determine of gene expression changes in serotonin receptors (5HT2AR and 5HT3AR) may 
be useful as a new approach in treatment of breast cancer based on use of antagonists. 
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commonplace disease between women but 1-2 percent 
of patients were men and because of their late diagnosis, 
men have a higher mortality rate (Donegan and Redlich, 
1996; Haghighat et al., 2012). Whereas the greatest risk 
factor for breast cancer are female, ageing parity, and 
breastfeeding inheritance, but environmental factors are 
critically important in initiation of disease (Helmrich et 
al., 1983; Akbari et al., 2011). Environmental factors like 
stress, can lead to the disruption of the balance of central 
nervous system and immune system. Relationship between 
stress and breast cancer development remain controversial 
(Pinquart and Duberstein, 2010; Antonova et al., 2011). 
Many researchers believed that mental and psychological 
conditions have a fundamental role in progression of 
cancers (Reiche et al., 2004). Interaction and balance of 
nervous and immune systems are essential for maintaining 
of homeostasis. There are strong evidence that the CNS, 
endocrine and immune system talk to each other and 
this process mediated with neurotransmitters (serotonin, 
norepinephrine and dopamine), neurohormons (growth 
hormone and prolactin) and cytokines (interleukin1, 
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TNFα, interferon α and γ) (Reiche et al., 2004). Serotonin 
is one of the most ancient neurotransmitter and its 
receptor is found in divers’ organism from planaria to 
human. The serotonin has several roles in normal brain 
including mood state, memory, anxiety, emotion, sex 
,sleep and many others (Webster et al., 2002). Serotonin 
or 5-hydroxytryptamine (5-HT) receptor includes seven 
classes from 5HTR1 to 5HTR7 and many subtypes. 
The 5HT2A class is subdivided into 5HT2a, 5HT2b and 
5HT2c which are coupled to G-Protein. 5HT3A receptor, 
an inotropic receptor, affects the potassium voltage gated 
channel, permit actions sensitive to Na+ and play important 
role in regulation of Na+ /K+ movement in some immune 
cells (Kopparapu et al., 2013). Furthermore, some studies 
showed that serotonin can promote transition T cells 
from S-phase to G2/M in the cell cycle via serotonin 
receptors such as 5HT2A and 5HT3A receptors. On 
the other hand, some studies revealed that stressful 
conditions have an inhibitory role in immune system 
cells including T- lymphocyte mitogenesis, natural killer 
cell (NKC) activity and production of interleukin 2 and 
interferon γ (Reiche et al., 2004). That is one of the most 
important mechanisms against development of tumors 
cells. So, the study of serotonin receptors gene expression 
changes in the progression of breast cancer patient seems 
unavoidable. The major aim of this study is to evaluate 
the relationship between increasing incidence of breast 
cancer and psychosocial stress factor at molecular level. 
 
Materials and Methods
 We studied the thirty patients suffering from breast 
cancer, admitted to the CRC and demographic data of 
Shohada Hospital of Tehran, Iran, were enrolled in this 
study. Five mL of peripheral blood samples was taken 
from each patient, among which there were 1 male and 
29 female. The patient population had a mean age of 
34 years and ranged from 20 to 40 years. Samples were 
also taken from 30 healthy subjects, of which there were 
15 male and 15 female. The healthy group had a mean 
age of 35years, where ages ranged from 20 to 40 years. 
Healthy participants were excluded provided that they 
were diagnosed with cigarette smoking, alcohol drinking 
or mental illness.
All clinical procedures were approved by the local ethical 
committee of CRC Shohada Hospital. All participants 
gave their informed consent prior to their inclusion in 
the study. PBMCs from collected samples were isolated 
using density gradient centrifuge by Ficoll-Hypaque 
(Pharmacia, Uppsala, Sweden) density centrifugation 
whose density was 1.077±0.001 g/ml (20˚C) and its 
osmolity 290±15 mosm. Horizontal swing out centrifuge 
was used for cells isolation with 2500 rpm, at 20 minute 
and 1.0 speed regulation. The buffy coat (lymphocyte 
layer) was collected and centrifuged with 1600 rpm, at 
10 minute and 2.0 gulation. Finally the resulting pellet 
was washed three times in Phosphate buffer saline (PBS), 
resulting in a final count of 106 to 3×106 cells for total 
RNA extraction. MCF7 breast cancer cell line provided 
from Gibco (Germany) and Pasture institute of Iran. The 
cells were cultured in DMEM supplemented with 10 
percent fetal bovine serum. To evaluate gene expression 
of serotonin receptors, 1×106 of MCF-7 cells were used 
for RNA extraction
 Total RNA was extracted using High pure RNA 
isolation kit (Roche, Germany) according to the 
manufacturer’s instructions. To confirm existing total 
RNA in the samples and to verify previous steps, we 
continued by conventional PCR and gel electrophoresis. 
The RNA extracted samples read with Nano drop to 
measuring the RNA concentration in samples and in this 
stage we synchronize all other samples. The RNA (1µg) 
from each sample was used to synthesize first-strand 
cDNA by using cDNA Synthesis Kit Fermentase, USA. 
PCR cycles used Techne Flexigen, Minneapolis, MN, 
USA. PCR products were separated using 2% agarose gel 
electrophoresis supplemented with Ethidium bromide for 
DNA product visualization under UV light. After verifying 
RNA extraction, product was amplified using RT-PCR 
with primer sets specific for 5HT3AR and 5HT2AR. Also 
Beta-actin was used as an internal control (Table I). Beta-
actin, 5HT2AR and 5-HT3AR transcripts were quantified 
in samples using real time PCR (Rotor gene, Corbett, 
Germany) and light cycler fast start DNA master plus 
SYBR green I kit (Roche, Germany) with specific primer 
(Table 1). PCR products of serotonin receptor Beta-actin, 
5HTR2A and 5-HT3A were sequenced by DNA sequencer 
ABI 3700 capillary system (Applied Biosystem, USA) to 
confirm amplicon sequences. The number of samples was 
determined by Minitab 16.1 software. Efficiency of each 
reaction was determined precisely by Linreg software. 
Real time PCR data were analyzed by Rest 2005 and 2009 
software. The relationship between changes in serotonin 
receptor gene expression data obtained from case patients 
on age, disease stage, HER2 and ER gene expression was 
evaluated by SPSS 16.0 software. Also, the relationship 
Significant value in this study was less than 0.05 (p<0.05).
Results 
 We examined the change in expression of serotonin 
receptor subtype 5HT3AR and 5HT2AR genes were 
evaluated in breast cancer patients PBMC, healthy 
individuals PBMC and human breast cancer cell line 
(MCF-7) by a highly sensitive method of real-time PCR. 
The amplicon sequences and size were corroborated using 
gel electrophoresis and sequencing. The results of RT-PCR 
showed that serotonin receptor subtype such as 5HT3AR 
and 5HT2AR were expressed in PBMC of breast cancer 
patient , healthy individuals and human breast cancer 
cell- line (MCF-7) as previously published (Sonier et al., 
2006; Shariati et al., 2009). 
 But there were differences between the genes 
expression rates. Compared to healthy persons’ PBMC, 
5HT3AR and 5HT2AR receptor genes expression rates 
were increased significantly in patient (Table 2). We also 
measured gene expression of serotonin receptors in MCF7 
cell line and compared them with patients and healthy 
persons. So, we found that 5HT3AR was increased in 
MCF-7 cells significantly compared with the healthy 
persons’ profile and mRNA rates of 5HTR2A receptor 
gene were significantly reduced as well. Also, it was 
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the first time that two types of receptors with different 
structure were evaluated simultaneity in breast cancer. 
Furthermore, 5HT2AR was decreased significantly in 
MCF-7 cell line in comparison to breast cancer patients’ 
PBMC (Table 2). Also, sequencing analysis by capillary 
sequencer did not showed any structural changes in genes 
in breast 5HT2AR and 5HT3AR cancer patients, compared 
to sequences available through NCBI. Investigate the 
relationship between serotonin receptor gene expression 
with age, disease stage, HER2 and ER expression showed 
that 5HT3AR gene expression was significantly increased 
in all stages of breast cancer (Table 3). However, such a 
significant relationship between increased expressions 
of 5HT2AR receptor with different stages of disease was 
not observed. There were also no significant association 
between serotonin receptor gene expression increases with 
age of the patient, human estrogen Receptor (HER2) and 
estrogen receptor (ER) genes expression. 
Discussion
Serotonin is an ancient neurotransmitter with a long 
evolutionary history and serotonin receptor virtually 
exist in peripheral blood cells and all of region of central 
nervous system and play different roles in sleep, memory, 
mood, aggression, appetite and sex. (Prelusky, 1996). It 
has been demonstrated that distress among breast cancer 
patients can be reduced via group therapy for women 
especially those with high initial distress (Yavuzsen et 
al., 2012). So far, the relationship between depression and 
breast cancer remain controversial. There are different 
reports for promoting and descending the risk of breast 
cancer through depression conditions (Persky et al., 1987; 
Schoevers et al., 2000; Aro et al., 2005; Nazlican et al., 
2012). Many studies indicated that some cytokine (IL-1b, 
IF-a, IF- c and TNF-α) whether directly or indirectly can 
modulate metabolism of serotonin via peripheral depletion 
of tryptophan. Also, some cytokines can stimulate HPA 
axis and induce depression (Leonard, 2010). Depression 
has been shown that attenuate of the immune system as 
lower NKC activity and T cell subpopulations are occurred 
which are needed to defense against cancer disease. Also, 
the level of tryptophan as a precursor of serotonin is low 
in depression mood and tryptophan–free amino acid diet 
has a negative effect on therapeutic anti depression drug 
(Herbert and Cohen, 1993). Some anti-depression drugs 
like serotonin specific reuptake inhibitor (SSRI) can 
inhibit reuptake of serotonin and increase the serotonin 
level in synaptic clefts (Moorman et al., 2003; Wang et 
al., 2001). Some clinical studies demonstrated that 5HT3A 
receptor antagonists have anxiolytic effects in humans. 
The presence of serotonin receptors on the PBMC cells 
and nervous system indicates the role of serotonin in 
relationship between CNS and immune system. Thus, 
disruption in this relation can lead to relieve the symptoms 
of cancer. In a dose-dependent manner mitogenic, the 
effect of serotonin on B-lymphocyte proliferation and 
hepatocytes has been observed (Iken et al., 1995). 
Phospholipase D (PLD) dependent protein kinase C 
(PKC) pathway can be activated in T-cells via induction 
of 5HT3AR (Khan and Hichami, 1999). Serotonin also 
has a mitogen effect on hepatocytes and promotes liver 
regeneration (Soll et al., 2009). Serotonin cooperates as 
a growth factor in several type of cancer and non-cancer 
cells (Siddiqui et al., 2005). This data was in line with 
our results which showing increases level of 5HT3AR 
expression not only in PBMC on breast cancer patient 
but also in MCF7 cell line compared to normal individual 
PBMC.
Also, 5HT2AR, a member of G-protein-coupled 
receptors, is expressed in several tissues and has variety 
of functions (Hannon and Hoyer, 2008) including: 
arterial fibroblast proliferation via mitogen activated 
protein kinase (MAPK) pathway (Welsh et al., 2004) 
and migration of aortic muscle cell by activation of PLC 
and PKC pathways (Cogolludo et al., 2006). Another 
researchers reported that increase level of 5HT2AR 
and activity of serotonin lead to apoptosis and activity 
of 5HT1AR decreased apoptotic signaling via kaspas3 
suppression (Adayev et al., 2003). 
Moreover, different expression pattern of serotonin 
receptors (5-HTRs) was observed in patient with breast 
cancer and this diversity can be applied as a prominent 
Table 1. Primer Sequences used in RT-PCR and Real Time PCR
Locus Primers Accession number Amplicon size
B-actin-forward 5’- AGACGCAGGATGGCATGGG-3’ NM_001101.3 161bp
B-actin-reverse 5’-GAGACCTTCAACACCCCAGCC-3’  
5HT2AR -forward 5’- TTGGGCTACAGGACGATT -3’ NM_001165947.2 383bp
5HT2AR -reverse 5’- GAAGAAAGGGCACCACATC -3’  
5HT3AR-forward 5’- CTATGTGGTCATCCGCCGG -3’ NM_001161772.2 457bp
5HT3AR- reverse 5’- CTATGTGGTCATCCGCCG -3’  
Table 2. Compared to Healthy Persons’ PBMC 
5HT2AR &5HT3AR Genes Expression in Breast 
Cancer Patients PBMCs were Increased Significantly 
Gene p value Rate of changes Changes
5HT2AR 0.027 2.769±2.4 UP
5HT3AR 0.001 3.6±2.8 UP
5HT2AR* 0.045 5.9±0.00097 DOWN
5HT3AR* 0.002 6.4±3.9 UP
* In human breast cancer cells (MCF-7), 5HT3AR had significant promotion in 
comparison to healthy individuals’ PBMCs, but 5HT2AR was decreased
Table 3. Relationship between Changes in 5HT3AR 
Gene Expression and Disease Stages
5HT3AR   ANOVA  
 Sum of Squares df Mean Square F Sig.
Between Groups 114.216 3 38.072 4.780 .012
Within Groups 151.327 27 7.965  
Total 265.543 30   
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index for understanding the distribution and function 
of each subtype in the pathogenesis of breast cancer 
(Kopparapu et al., 2013). Modification of 5HT2AR 
can promote the risk of breast cancer. Also, the results 
of this study indicated that expression of 5HTR2a was 
increased in breast cancer patients PBMC compare to 
healthy individuals. While, expression of this receptor 
has descending effects on MCF-7 cells significantly. 
In conclusion, simultaneity analysis of 5HT2AR and 
5HT3AR showed that 5HT3AR increases and 5HT2AR 
descending expression in MCF-7 cell line can promote 
the risk of breast cancer. 
At least, regarding to these studies observations, 
performing of additional studies using 5HT3AR 
antagonists and 5HT2AR agonists as new therapeutic 
strategy and definition of serotonin receptors gene 
expression profile for the diagnosis and curmeant of breast 
cancer patients seems hopeful.
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